# Outcomes of tumor necrosis factor inhibitor cycling versus switching to a disease-modifying anti-rheumatic drug with a new mechanism of action among patients with rheumatoid arthritis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/outcomes-of-tumor-necrosis-factor-inhibitor-cycling-versus-switching-to-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Benjamin Chastek,Laura Becker,Chieh-I Chen,Puneet Mahajan,Jeffrey R. Curtis |
| Citations | 37 |
| DOI | 10.1080/13696998.2016.1275653 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.tandfonline.com/doi/pdf/10.1080/13696998.2016.1275653?needAccess=true&role=button |
| OpenAlex ID | https://openalex.org/W2565750495 |
| PMID | 28010149 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Benjamin Chastek](https://scholariq.org/researchers/benjamin-chastek/)

## Paper journal

- [Journal of Medical Economics](https://scholariq.org/journals/journal-of-medical-economics/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.